• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自体造血干细胞移植后水痘带状疱疹病毒再激活是骨髓瘤患者中的常见事件,且与良好预后相关。

Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.

作者信息

Kamber C, Zimmerli S, Suter-Riniker F, Mueller B U, Taleghani B M, Betticher D, Zander T, Pabst T

机构信息

Department of Medical Oncology, University Hospital and University of Bern, Bern, Switzerland.

Department of Infectious Diseases, University Hospital and University of Bern, Bern, Switzerland.

出版信息

Bone Marrow Transplant. 2015 Apr;50(4):573-8. doi: 10.1038/bmt.2014.290. Epub 2015 Jan 19.

DOI:10.1038/bmt.2014.290
PMID:25599166
Abstract

The occurrence of varicella zoster virus (VZV) reactivation is increased after allogeneic transplantation, whereas limited data are available for herpes zoster (HZ) after autologous SCT (ASCT). We determined the incidence and the prognostic significance of HZ and its correlation with VZV serology in 191 consecutive myeloma patients undergoing high-dose melphalan chemotherapy with ASCT. We found that VZV reactivation occurred in 57 (30%) patients, in 8.5% during induction and in 21.5% after ASCT peaking at 8 months after ASCT. Disease burden due to HZ was assessed as high or rather high in 70% of the patients. By immune fluorescence and Serion Elisa VZV IgG assessment, 90.8% of all patients had specific anti-VZV antibodies at ASCT. Lower specific antibody titers at transplantation were observed in patients with HZ after ASCT than in those without reactivation (P=0.009). Finally, OS was better in myeloma patients with HZ after ASCT compared with patients without HZ (P=0.007). Our data indicate that VZV reactivation after ASCT is a frequent event carrying a significant disease burden and it is associated with improved survival. Low levels of specific VZV antibodies at ASCT suggest increased vulnerability for VZV reactivation.

摘要

异基因移植后水痘带状疱疹病毒(VZV)再激活的发生率会升高,而关于自体干细胞移植(ASCT)后带状疱疹(HZ)的数据有限。我们确定了191例接受大剂量美法仑化疗并进行ASCT的连续性骨髓瘤患者中HZ的发生率、预后意义及其与VZV血清学的相关性。我们发现57例(30%)患者发生了VZV再激活,诱导期为8.5%,ASCT后为21.5%,在ASCT后8个月达到峰值。70%的患者中HZ所致的疾病负担被评估为高或相当高。通过免疫荧光和Serion Elisa VZV IgG评估,90.8%的患者在ASCT时有特异性抗VZV抗体。ASCT后发生HZ的患者在移植时的特异性抗体滴度低于未再激活的患者(P=0.009)。最后,ASCT后发生HZ的骨髓瘤患者的总生存期(OS)优于未发生HZ的患者(P=0.007)。我们的数据表明,ASCT后VZV再激活是常见事件,伴有显著的疾病负担,且与生存期改善相关。ASCT时特异性VZV抗体水平低表明VZV再激活的易感性增加。

相似文献

1
Varicella zoster virus reactivation after autologous SCT is a frequent event and associated with favorable outcome in myeloma patients.自体造血干细胞移植后水痘带状疱疹病毒再激活是骨髓瘤患者中的常见事件,且与良好预后相关。
Bone Marrow Transplant. 2015 Apr;50(4):573-8. doi: 10.1038/bmt.2014.290. Epub 2015 Jan 19.
2
A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation.一项日本单中心观察性试验,对自体外周血干细胞移植后水痘带状疱疹病毒再激活进行回顾性病例对照分析。
Transpl Infect Dis. 2015 Aug;17(4):544-50. doi: 10.1111/tid.12406. Epub 2015 Jul 3.
3
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.在接受那他珠单抗治疗的多发性硬化症患者中,存在水痘-带状疱疹病毒再激活或再感染易感性增加的血清学证据。
Mult Scler. 2015 Dec;21(14):1823-32. doi: 10.1177/1352458515576984. Epub 2015 Mar 31.
4
Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.血清学表明巨细胞病毒感染与水痘-带状疱疹病毒再激活有关。
J Med Virol. 2014 May;86(5):812-9. doi: 10.1002/jmv.23749. Epub 2013 Sep 13.
5
Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.造血干细胞移植受者中既往抗水痘-带状疱疹病毒(VZV)抗体与临床VZV再激活之间的关系。
J Clin Microbiol. 2006 Dec;44(12):4441-3. doi: 10.1128/JCM.01312-06. Epub 2006 Oct 11.
6
Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.同种异体干细胞移植后,通过同种异型分析来区分水痘带状疱疹病毒免疫球蛋白 G 的来源。
Biol Blood Marrow Transplant. 2013 Jul;19(7):1013-20. doi: 10.1016/j.bbmt.2013.04.007. Epub 2013 Apr 10.
7
Varicella-zoster reactivation after allogeneic stem cell transplantation without routine prophylaxis--the incidence remains high.异基因造血干细胞移植后未进行常规预防的水痘-带状疱疹病毒再激活——发病率仍然很高。
Biol Blood Marrow Transplant. 2014 Oct;20(10):1646-9. doi: 10.1016/j.bbmt.2014.06.002. Epub 2014 Jun 7.
8
Disseminated zoster in an adult patient with extensive burns: a case report.成人广泛烧伤患者的播散性带状疱疹:病例报告。
Virol J. 2019 May 23;16(1):68. doi: 10.1186/s12985-019-1179-8.
9
Varicella-zoster virus prophylaxis with low-dose acyclovir in patients with multiple myeloma treated with bortezomib.硼替佐米治疗的多发性骨髓瘤患者中低剂量阿昔洛韦预防水痘-带状疱疹病毒感染
Clin Lymphoma Myeloma. 2009 Apr;9(2):151-3. doi: 10.3816/CLM.2009.n.036.
10
Daily 500 mg valacyclovir is effective for prevention of Varicella zoster virus reactivation in patients with multiple myeloma treated with bortezomib.每日 500 毫克伐昔洛韦可有效预防硼替佐米治疗多发性骨髓瘤患者水痘带状疱疹病毒再激活。
Anticancer Res. 2012 Dec;32(12):5437-40.

引用本文的文献

1
Systematic Literature Review on the Incidence of Herpes Zoster in Populations at Increased Risk of Disease in the EU/EEA, Switzerland, and the UK.欧盟/欧洲经济区、瑞士和英国疾病风险增加人群中带状疱疹发病率的系统文献综述。
Infect Dis Ther. 2024 May;13(5):1083-1104. doi: 10.1007/s40121-024-00963-w. Epub 2024 Apr 24.
2
Oncolytic varicella-zoster virus engineered with ORF8 deletion and armed with drug-controllable interleukin-12.携带 ORF8 缺失并武装了药物可控白细胞介素 12 的溶瘤水痘-带状疱疹病毒。
J Immunother Cancer. 2024 Mar 25;12(3):e008307. doi: 10.1136/jitc-2023-008307.
3
Towards personalized prevention of Herpes zoster infection in patients with hematologic diseases or hematopoietic stem cell transplant recipients: a position paper from an <I>ad hoc</I> Italian expert panel.

本文引用的文献

1
Vaccination against zoster remains effective in older adults who later undergo chemotherapy.带状疱疹疫苗对随后接受化疗的老年人仍然有效。
Clin Infect Dis. 2014 Oct;59(7):913-9. doi: 10.1093/cid/ciu498. Epub 2014 Aug 4.
2
Incidence of herpes zoster in patients with altered immune function.免疫功能改变患者的带状疱疹发病率。
Infection. 2014 Apr;42(2):325-34. doi: 10.1007/s15010-013-0550-8. Epub 2013 Nov 10.
3
Safety and immunogenicity of heat-treated zoster vaccine (ZVHT) in immunocompromised adults.免疫功能低下成年人中经热处理的带状疱疹疫苗(ZVHT)的安全性和免疫原性。
针对血液系统疾病或造血干细胞移植受者中带状疱疹感染的个体化预防:来自意大利专家组的一份立场文件。
Haematologica. 2024 Nov 1;109(11):3496-3504. doi: 10.3324/haematol.2023.284417.
4
The effect of varicella-zoster virus reactivation on the long-term outcomes of patients undergoing allogeneic hematopoietic stem cell transplantation.水痘带状疱疹病毒再激活对异基因造血干细胞移植患者长期结局的影响。
J Health Popul Nutr. 2023 Oct 2;42(1):105. doi: 10.1186/s41043-023-00429-8.
5
Autologous NK cells as consolidation therapy following stem cell transplantation in multiple myeloma.自体自然杀伤细胞作为多发性骨髓瘤干细胞移植后的巩固治疗。
Cell Rep Med. 2022 Jan 28;3(2):100508. doi: 10.1016/j.xcrm.2022.100508. eCollection 2022 Feb 15.
6
Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview.免疫功能低下成人中含佐剂的重组带状疱疹疫苗的免疫应答:全面综述。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4132-4143. doi: 10.1080/21645515.2021.1930846. Epub 2021 Jun 30.
7
Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies.在使用阿昔洛韦或伐昔洛韦预防以及新型治疗和维持疗法时代,自体造血细胞移植受者中的带状疱疹
Biol Blood Marrow Transplant. 2017 Mar;23(3):505-511. doi: 10.1016/j.bbmt.2016.12.620. Epub 2016 Dec 28.
8
Meta-analysis on autologous stem cell transplantation in the treatment of limb ischemic.自体干细胞移植治疗肢体缺血的荟萃分析。
Int J Clin Exp Med. 2015 Jun 15;8(6):8740-8. eCollection 2015.
9
Immortal person-time bias in the association between herpes zoster and survival following autologous stem cell transplantation.
Bone Marrow Transplant. 2015 Jun;50(6):878-9. doi: 10.1038/bmt.2015.66. Epub 2015 Mar 30.
J Infect Dis. 2013 Nov 1;208(9):1375-85. doi: 10.1093/infdis/jit344. Epub 2013 Aug 1.
4
Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study.带状疱疹疫苗对美国老年人群中带状疱疹和带状疱疹后神经痛的有效性:一项队列研究。
PLoS Med. 2013;10(4):e1001420. doi: 10.1371/journal.pmed.1001420. Epub 2013 Apr 9.
5
Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.接种带状疱疹疫苗与特定免疫介导性疾病老年患者带状疱疹感染风险的相关性。
JAMA. 2012 Jul 4;308(1):43-9. doi: 10.1001/jama.2012.7304.
6
Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.带状疱疹疫苗在 50-59 岁人群中的疗效、安全性和耐受性。
Clin Infect Dis. 2012 Apr;54(7):922-8. doi: 10.1093/cid/cir970. Epub 2012 Jan 30.
7
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.国际骨髓瘤工作组共识方法治疗适合自体干细胞移植的多发性骨髓瘤患者。
Blood. 2011 Jun 9;117(23):6063-73. doi: 10.1182/blood-2011-02-297325. Epub 2011 Mar 29.
8
Long-term ultra-low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation.长期小剂量阿昔洛韦预防异基因造血干细胞移植后水痘带状疱疹病毒再激活
Am J Hematol. 2008 Jun;83(6):472-6. doi: 10.1002/ajh.21152.
9
Factors influencing varicella zoster virus infection after allogeneic peripheral blood stem cell transplantation: low-dose acyclovir prophylaxis and pre-transplant diagnosis of lymphoproliferative disorders.异基因外周血干细胞移植后影响水痘带状疱疹病毒感染的因素:低剂量阿昔洛韦预防及移植前淋巴增殖性疾病的诊断
Transpl Infect Dis. 2008 Apr;10(2):90-8. doi: 10.1111/j.1399-3062.2007.00247.x. Epub 2007 Jul 1.
10
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation.造血细胞移植后预防水痘-带状疱疹病毒病的一年期阿昔洛韦预防治疗:停药后无水痘-带状疱疹病毒病复发的证据
Blood. 2007 Oct 15;110(8):3071-7. doi: 10.1182/blood-2007-03-077644. Epub 2007 May 21.